RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 16 Sep 2024
Last Applicant/ Owned by
82166 Gräfelfing
DE
Serial Number
79378687 filed on 28th Jun 2023
Registration Number
N/A
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
MIMBB75
Pharmaceuticals for the treatment of irritable bowel syndrome and gastrointestinal discomfort; probiotic preparations for medical use; dietetic preparations adapted for medical purposes and food supplements for medical use; bacterial preparations for medical and veterinary use; bacterial strains for medical and veterinary use, all of the foregoing goods containing bacterial strains of Bifidobacter Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment of irritable bowel syndrome and gastrointestinal discomfort; probiotic preparations for medical use; dietetic preparations adapted for medical purposes and food supplements for medical use; bacterial preparations for medical and veterinary use; bacterial strains for medical and veterinary use, all of the foregoing goods containing bacterial strains of Bifidobacterium bifidum MIMBb75
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79378687
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Dec 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 02th Dec 2024 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| 20th Nov 2024 | ASSIGNED TO LIE |
| 19th Nov 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 17th Sep 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 17th Sep 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 17th Sep 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 17th Sep 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 17th Sep 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 16th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |